{"name":"CoCrystal Pharma","slug":"cocrystal-pharma","ticker":"COCP","exchange":"NASDAQ","domain":"cocrystalpharma.com","description":"","hq":"Bothell, WA","founded":0,"employees":"","ceo":"","sector":"Antivirals / Clinical-Stage Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":12712091,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CDI-31244","genericName":"CDI-31244","slug":"cdi-31244","indication":"Treatment of COVID-19","status":"phase_2"},{"name":"CC-42344","genericName":"CC-42344","slug":"cc-42344","indication":"Treatment of COVID-19","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"CDI-988","genericName":"CDI-988","slug":"cdi-988","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CDI-31244","genericName":"CDI-31244","slug":"cdi-31244","phase":"phase_2","mechanism":"CDI-31244 is a small molecule inhibitor targeting the SARS-CoV-2 main protease.","indications":["Treatment of COVID-19"],"catalyst":""},{"name":"CDI-988","genericName":"CDI-988","slug":"cdi-988","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CC-42344","genericName":"CC-42344","slug":"cc-42344","phase":"phase_2","mechanism":"CC-42344 is a small molecule inhibitor of the SARS-CoV-2 main protease.","indications":["Treatment of COVID-19"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}